Physician

Antoine Rizk, M.D.

According to 2025 Medicare claims, Antoine Rizk, M.D. (NPI: 1568411403) practices cardiology in the Gulfport-Biloxi, MS market, with the plurality of this provider's patient population coming from Harrison, MS. This provider's primary affiliated billing organization is MEMORIAL HOSPITAL AT GULFPORT (NPI: 1093142598; TIN: 646010232) and primary practice location at 39501-2515. Rizk is affiliated with the Connected Care, LLC (ACO ID: A5709), participating under the MSSP model.

Rizk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,424 traditional Medicare patients, billed 11,284 HCPCS/CPT codes, and received $538,211 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,085 prescription claims across 302 beneficiaries totaling $201,730 in drug costs, led by Eliquis (Apixaban). DME data shows 144 claims. Open Payments data shows 134 records totaling $4,957. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $161,951 and ending at $201,730. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $22,787 to $9,357.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,103	7,707	$363,347
2016	2,767	10,344	$488,259
2017	2,738	11,594	$532,906
2018	3,015	12,159	$540,444
2019	3,099	12,512	$564,225
2020	2,635	11,172	$536,680
2021	2,501	10,741	$527,810
2022	2,291	10,500	$504,667
2023	2,467	11,256	$538,512
2024	2,424	11,284	$538,211

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	554	3,191	$161,951
2016	271	1,258	$104,487
2017	214	939	$128,671
2018	197	747	$178,248
2019	195	724	$151,067
2020	192	647	$64,785
2021	249	722	$73,667
2022	226	841	$184,688
2023	297	897	$167,065
2024	302	1,085	$201,730

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	17	194	$18,622
2016	17	156	$9,871
2017	13	127	$5,917
2018	12	126	$4,985
2019	15	172	$9,103
2020	16	160	$8,506
2021	21	277	$16,251
2022	41	391	$21,857
2023	13	239	$13,227
2024	11	144	$6,723

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,306	2,499	$74
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	731	810	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	609	773	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	396	442	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,339	2,145	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	118	5,754	$110,767
Entresto	Sacubitril/Valsartan	50	2,040	$43,818
Xarelto	Rivaroxaban	35	1,410	$25,621
Midodrine Hcl	Midodrine Hcl	11	900	$1,183
Rosuvastatin Calcium	Rosuvastatin Calcium	68	4,980	$1,030

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	11	81	$5,608
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	36	$537
E1392	Portable oxygen concentrator, rental	Y	N/R	14	$462
E0562	Humidifier, heated, used with positive airway pressure device	Y	N/R	13	$116

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	134	$4,957	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Antoine Rizk, M.D.?

Tedicare shows public-source Medicare data for Antoine Rizk, M.D. (NPI 1568411403), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Antoine Rizk, M.D. have ACO affiliation data?

Antoine Rizk, M.D. is shown with ACO affiliation data for Connected Care, LLC (MSSP, ACO ID A5709).

What billing organization is linked to Antoine Rizk, M.D.?

Antoine Rizk, M.D. is linked to MEMORIAL HOSPITAL AT GULFPORT (billing NPI 1093142598) in the available physician profile data.

Does Antoine Rizk, M.D. have Open Payments data?

Antoine Rizk, M.D. has 134 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.